Search
CONGRESS 2023 - Learning and training support for the Certificates of Achievement
26/09/2023
The IBMS Certificates of Achievement are designed as gateway qualifications to reflect the training needs of people working as Assistant Practitioners or Associate Practitioners in laboratory services.
In this ‘show and tell’ session designed for trainees, training officers, training managers or laboratory managers, we will outline the structure of the Certificates of achievement and give some information on the support and guidance that the IBMS currently offer for completing both parts of this qualification. We will interactively explore how the resources available as a result of our recent collaboration with LearnSci can supplement the existing training matter you have in your laboratory, to help you scaffold and deliver engaging, supportive and enjoyable training experiences to those completing this qualification.
We will also canvass the views of everyone present in this talk to better understand the needs of each group and to gain insight into the resources and support that attendees would find useful, to help the IBMS drive the evolution of this qualification by ensuring it remains relevant and useful to practitioners.
In this ‘show and tell’ session designed for trainees, training officers, training managers or laboratory managers, we will outline the structure of the Certificates of achievement and give some information on the support and guidance that the IBMS currently offer for completing both parts of this qualification. We will interactively explore how the resources available as a result of our recent collaboration with LearnSci can supplement the existing training matter you have in your laboratory, to help you scaffold and deliver engaging, supportive and enjoyable training experiences to those completing this qualification.
We will also canvass the views of everyone present in this talk to better understand the needs of each group and to gain insight into the resources and support that attendees would find useful, to help the IBMS drive the evolution of this qualification by ensuring it remains relevant and useful to practitioners.
CONGRESS 2023 - Obstetric guidelines - what's new?
26/09/2023
This presentation will:
Summarise the key points within the BSH guideines for blood grouping and antibody testing in pregnancy
Give an overview of the main updates to the BSH guideline for blood grouping and antibody testing in pregnancy
Summarise the key points within the BSH guideines for blood grouping and antibody testing in pregnancy
Give an overview of the main updates to the BSH guideline for blood grouping and antibody testing in pregnancy
CONGRESS 2023 - Pathology Network Accreditation
26/09/2023
Pathology services across the UK are increasingly working together as formal or informal networks, to support improved patient care.
This session provides an overview of accreditation options and considerations for pathology networks.
This session provides an overview of accreditation options and considerations for pathology networks.
CONGRESS 2023 - Post-pandemic respiratory viral infections in hospitals
26/09/2023
Post-pandemic respiratory viral infections in hospitals
CONGRESS 2023 - Precision medicine and its impact on health and health delivery
26/09/2023
NHS England established the Genomic Medicine Service (GMS) in 2018 to realise the potential of genomics in healthcare. The NHS GMS built upon the existing NHS infrastructure and used learnings from the 100,000 Genomes Project to embed genomics through a world leading innovative service model from primary and community care through to specialist and tertiary care.
A consolidated national genomic laboratory network was established with seven GMS Alliances working together to support the clinical leadership and embedding of genomic medicine in end-to-end pathways more broadly and the working with other key clinical specialties. Equitable genomic testing is delivered through a single mandated National Genomic Test Directory for improved outcomes in cancer, rare, inherited and common diseases, and in enabling precision medicine and reducing adverse drug reactions.
Working in partnership with Genomics England the delivery of the whole genome sequencing service and ongoing key research initiatives are integral in developing the genomic service. Ongoing evolution of the service through cutting-edge science, research and innovation to ensure that patients can benefit from rapid implementation of advances is critical.
A consolidated national genomic laboratory network was established with seven GMS Alliances working together to support the clinical leadership and embedding of genomic medicine in end-to-end pathways more broadly and the working with other key clinical specialties. Equitable genomic testing is delivered through a single mandated National Genomic Test Directory for improved outcomes in cancer, rare, inherited and common diseases, and in enabling precision medicine and reducing adverse drug reactions.
Working in partnership with Genomics England the delivery of the whole genome sequencing service and ongoing key research initiatives are integral in developing the genomic service. Ongoing evolution of the service through cutting-edge science, research and innovation to ensure that patients can benefit from rapid implementation of advances is critical.
CONGRESS 2023 - Tackling health inequality – a lesson learned from COVID-19 pandemic
26/09/2023
Health inequalities are unfair and avoidable differences in health across the population, and between different groups within society. Health inequalities arise because of the conditions in which we are born, grow, live, work and age. These conditions influence our opportunities for good health, and how we think, feel and act, and this shapes our mental health, physical health, and wellbeing. The COVID-19 shone harsh light on the pre-existing health inequalities which persist in our society. It has become increasingly clear that COVID-19 has had a disproportionate impact on many who already face disadvantage and discrimination. The impact of the virus has been particularly detrimental on people living in areas of high socio-economic deprivation, on people from Black, Asian and minority ethnic minority communities and those with a learning disability.
In England, there is a 19-year gap in healthy life expectancy (whether we experience health conditions or diseases that impact how long we live in good health) between the most and least affluent areas of the country, with people in the most deprived neighbourhoods, certain ethnic minority and inclusion health groups getting multiple long-term health conditions 10 to 15 years earlier than the least deprived communities, spending more years in ill health and dying sooner.
The Biomedical Sciences have a significant and pivotal role to play in narrowing the health inequalities gap through Research, Innovation and Life Sciences and its extensive reach across clinical practice within the NHS.
In England, there is a 19-year gap in healthy life expectancy (whether we experience health conditions or diseases that impact how long we live in good health) between the most and least affluent areas of the country, with people in the most deprived neighbourhoods, certain ethnic minority and inclusion health groups getting multiple long-term health conditions 10 to 15 years earlier than the least deprived communities, spending more years in ill health and dying sooner.
The Biomedical Sciences have a significant and pivotal role to play in narrowing the health inequalities gap through Research, Innovation and Life Sciences and its extensive reach across clinical practice within the NHS.
CONGRESS 2023 - The changing epidemiology of Crimean-Congo haemorrhagic fever (CCHF)
26/09/2023
Crimean-Congo haemorrhagic fever is the most widely distributed hard tick-borne disease in the world.
Different factors, such as a better knowledge of the disease, but also trade, modifications of the migratory bird routes and, probably, the climate change are favouring its increase.
The example of the emergence in Spain will be reviewed.
Different factors, such as a better knowledge of the disease, but also trade, modifications of the migratory bird routes and, probably, the climate change are favouring its increase.
The example of the emergence in Spain will be reviewed.
CONGRESS 2023 - The purpose and value of level 2 and 4 apprenticeships
26/09/2023
This talk will focus on how level 2 and level 4 apprenticeships can help to engage in widening participation and EDI agenda as well as create an entry level workforce pipeline and staff that can be grown through apprenticeship progression routes into the Biomedical science profession.
Page 18 of 47